1) Suicide prevention model.
2) Risk stratification in predicting suicide attempt.
3) Genetic predisposition for depression.
"Ayeshah graduated from the School of Medicine at the Royal College of Surgeons in Ireland - Bahrain campus. Following her graduation, she worked as a medical intern at King Hamad University Hospital and as a Research Analyst at SBI Pharmaceuticals Co., Ltd. Upon completing her internship in Bahrain, she moved back to Toronto. Despite her strong credentials, her years away from Toronto served as an obstacle for her to transition into the Canadian healthcare workforce.
Ayeshah joined the Internationally Trained Medical Doctors (ITMD) Bridging Program in April of 2017. This program proved to be the gateway she desired to re-enter the Canadian healthcare workforce. She completed her practicum at the Centre for Addiction and Mental Health (CAMH), the largest epicentre of mental health treatment and research in Canada. During her practicum, she actively contributed to research in the use of Transcranial Magnetic Stimulation in Autism Spectrum Disorders. She then worked at GlaxoSmithKline (GSK) as a clinical support lead in Clinical Development, supporting the vaccine zoster project before returning to CAMH. Ayeshah is currently working as a research assistant at the Neurogenetics Section at CAMH supporting the IMPACT (Individualized Medicine: Pharmacogenetic Assessment and Clinical Treatment) study and other studies. She aspires to pursue a Ph.D. in Neuroscience with specialization in Molecular Genetics and practice as a clinician-scientist in the future."
[wpv-view name=”student-capstone-view” limit=”1″]